Literature DB >> 9520444

Molecular anatomy of chromosome 7q deletions in myeloid neoplasms: evidence for multiple critical loci.

H Liang1, J Fairman, D F Claxton, P C Nowell, E D Green, L Nagarajan.   

Abstract

Complete or partial deletions of the long arm of chromosome 7 (7q- and -7) are nonrandom abnormalities seen in primary and therapy-induced myelodysplasia (MDS) and acute myelogenous leukemia (AML). Monosomy 7, occurring as the sole cytogenetic anomaly in a small but significant number of cases, may denote a dominant mechanism involving critical tumor suppressor gene(s). We have determined the extent of allele loss in cytogenetically prescreened MDS and AML patients for microsatellite markers from chromosome 7q22 and 7q31. Whereas >80% of these cases revealed allele loss for the entire region, a rare case of the 7q- chromosome showed allele loss for only the proximal 7q31.1 loci flanked by the markers D7S486 and D7S2456, and a case of monosomy 7 revealed allele loss for loci at both 7q31 and 7q22 with retention of sequences between these sets of loci. Furthermore, a case of AML with no cytogenetic anomaly of chromosome 7 revealed a submicroscopic allelic imbalance for a third distal locus, D7S677. These findings suggest the presence of three distinct critical loci that may contribute alone or in combination to the evolution of MDS and AML. The data also provide molecular evidence for unbalanced translocation with noncontiguous deletions, as an alternate mechanism underlying monosomy 7.

Entities:  

Mesh:

Year:  1998        PMID: 9520444      PMCID: PMC19914          DOI: 10.1073/pnas.95.7.3781

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  33 in total

1.  Detailed deletion mapping with a refined physical map of 7q31 localizes a putative tumor suppressor gene for breast cancer in the region of MET.

Authors:  J C Lin; S W Scherer; L Tougas; G Traverso; L C Tsui; I L Andrulis; S Jothy; M Park
Journal:  Oncogene       Date:  1996-11-07       Impact factor: 9.867

2.  Cytogenetic and molecular delineation of a region of chromosome 7 commonly deleted in malignant myeloid diseases.

Authors:  M M Le Beau; R Espinosa; E M Davis; J D Eisenbart; R A Larson; E D Green
Journal:  Blood       Date:  1996-09-15       Impact factor: 22.113

3.  Development of a sensitive PCR to detect allele loss in a model hematopoietic neoplasm.

Authors:  J Fairman; D Claxton; C L Williman; A B Deisseroth; L Nagarajan
Journal:  PCR Methods Appl       Date:  1994-08

Review 4.  Childhood monosomy 7: epidemiology, biology, and mechanistic implications.

Authors:  S Luna-Fineman; K M Shannon; B J Lange
Journal:  Blood       Date:  1995-04-15       Impact factor: 22.113

Review 5.  Cytogenetic, molecular and functional evidence for novel tumor suppressor genes on the long arm of human chromosome 7.

Authors:  J C Zenklusen; C J Conti
Journal:  Mol Carcinog       Date:  1996-03       Impact factor: 4.784

6.  Frequent clonal loss of heterozygosity but scarcity of microsatellite instability at chromosomal breakpoint cluster regions in adult leukemias.

Authors:  T Pabst; J Schwaller; M J Bellomo; M Oestreicher; D Mühlematter; A Tichelli; A Tobler; M F Fey
Journal:  Blood       Date:  1996-08-01       Impact factor: 22.113

7.  Frequent loss of heterozygosity at 7q31.1 in primary prostate cancer is associated with tumor aggressiveness and progression.

Authors:  S Takahashi; A L Shan; S R Ritland; K A Delacey; D G Bostwick; M M Lieber; S N Thibodeau; R B Jenkins
Journal:  Cancer Res       Date:  1995-09-15       Impact factor: 12.701

8.  Frequent loss of heterozygosity in human primary squamous cell and colon carcinomas at 7q31.1: evidence for a broad range tumor suppressor gene.

Authors:  J C Zenklusen; J C Thompson; A J Klein-Szanto; C J Conti
Journal:  Cancer Res       Date:  1995-03-15       Impact factor: 12.701

9.  Molecular definition of a narrow interval at 7q22.1 associated with myelodysplasia.

Authors:  E J Johnson; S W Scherer; L Osborne; L C Tsui; D Oscier; S Mould; F E Cotter
Journal:  Blood       Date:  1996-05-01       Impact factor: 22.113

10.  Rarity of microsatellite alterations in acute myeloid leukaemia.

Authors:  H Sill; J M Goldman; N C Cross
Journal:  Br J Cancer       Date:  1996-07       Impact factor: 7.640

View more
  24 in total

1.  Comparative analysis of the gene-dense ACHE/TFR2 region on human chromosome 7q22 with the orthologous region on mouse chromosome 5.

Authors:  M D Wilson; C Riemer; D W Martindale; P Schnupf; A P Boright; T L Cheung; D M Hardy; S Schwartz; S W Scherer; L C Tsui; W Miller; B F Koop
Journal:  Nucleic Acids Res       Date:  2001-03-15       Impact factor: 16.971

2.  A positive feedback loop between Pim-1 kinase and HBP1 transcription factor contributes to hydrogen peroxide-induced premature senescence and apoptosis.

Authors:  Shuya Wang; Zhengyi Cao; Junhui Xue; Hui Li; Wei Jiang; Yuning Cheng; Gang Li; Xiaowei Zhang
Journal:  J Biol Chem       Date:  2017-03-27       Impact factor: 5.157

3.  Human DMTF1β antagonizes DMTF1α regulation of the p14(ARF) tumor suppressor and promotes cellular proliferation.

Authors:  Mario P Tschan; Elena A Federzoni; Aladin Haimovici; Christian Britschgi; Bettina A Moser; Jing Jin; Venkateshwar A Reddy; Dennis A Sheeter; Kimberlee M Fischer; Peiqing Sun; Bruce E Torbett
Journal:  Biochim Biophys Acta       Date:  2015-07-15

4.  Use of chromosome engineering to model a segmental deletion of chromosome band 7q22 found in myeloid malignancies.

Authors:  Jasmine C Y Wong; Yan Zhang; Kenneth H Lieuw; Mary T Tran; Erna Forgo; Kelley Weinfurtner; Pilar Alzamora; Scott C Kogan; Keiko Akagi; Linda Wolff; Michelle M Le Beau; Nigel Killeen; Kevin Shannon
Journal:  Blood       Date:  2010-03-16       Impact factor: 22.113

5.  HMG box transcriptional repressor HBP1 maintains a proliferation barrier in differentiated liver tissue.

Authors:  H H Shih; M Xiu; S P Berasi; E M Sampson; A Leiter; K E Paulson; A S Yee
Journal:  Mol Cell Biol       Date:  2001-09       Impact factor: 4.272

6.  The tumor suppressor protein HBP1 is a novel c-myc-binding protein that negatively regulates c-myc transcriptional activity.

Authors:  Julienne R Escamilla-Powers; Colin J Daniel; Amy Farrell; Karyn Taylor; Xiaoli Zhang; Sarah Byers; Rosalie Sears
Journal:  J Biol Chem       Date:  2009-12-11       Impact factor: 5.157

7.  Targeted downregulation of caveolin-1 is sufficient to drive cell transformation and hyperactivate the p42/44 MAP kinase cascade.

Authors:  F Galbiati; D Volonte; J A Engelman; G Watanabe; R Burk; R G Pestell; M P Lisanti
Journal:  EMBO J       Date:  1998-11-16       Impact factor: 11.598

8.  Identifying the molecular signature of the interstitial deletion 7q subgroup of uterine leiomyomata using a paired analysis.

Authors:  Jennelle C Hodge; Peter J Park; Jonathan M Dreyfuss; Iman Assil-Kishawi; Priya Somasundaram; Luwam G Semere; Bradley J Quade; Allison M Lynch; Elizabeth A Stewart; Cynthia C Morton
Journal:  Genes Chromosomes Cancer       Date:  2009-10       Impact factor: 5.006

9.  Mutations in the ST7/RAY1/HELG locus rarely occur in primary colorectal, gastric, and hepatocellular carcinomas.

Authors:  S Yoshimura; T Yamada; S Ohwada; T Koyama; K Hamada; K Tago; I Sakamoto; I Takeyoshi; T Ikeya; F Makita; Y Iino; Y Morishita
Journal:  Br J Cancer       Date:  2003-06-16       Impact factor: 7.640

10.  CUX1 is a haploinsufficient tumor suppressor gene on chromosome 7 frequently inactivated in acute myeloid leukemia.

Authors:  Megan E McNerney; Christopher D Brown; Xiaoyue Wang; Elizabeth T Bartom; Subhradip Karmakar; Chaitanya Bandlamudi; Shan Yu; Jinkyung Ko; Barry P Sandall; Thomas Stricker; John Anastasi; Robert L Grossman; John M Cunningham; Michelle M Le Beau; Kevin P White
Journal:  Blood       Date:  2012-12-03       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.